NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...
Vous n'êtes pas connecté
NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech shows potential in autoimmune disease and transplant medicine.
NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company Isopogen, whose tech...
NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company...
NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company...
A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts calling it a milestone in the...
A Canadian nurse has kicked insulin to the curb after just one dose of an experimental stem cell therapy, with experts calling it a milestone in the...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude...
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
Actor Sam Milby recently underwent a medical process involving stem cell therapy to manage his diabetes.
By Lakshmy Ramakrishnan Biotechnology is a critical emerging technology holding significant potential in addressing various challenges,...
) PRESS RELEASE NEW PEER-REVIEWED DATA PROVIDE STRONG EVIDENCE SUPPORTING MASITINIB'S POTENTIAL FOR THE TREATMENT OF ALZHEIMER'S DISEASE THROUGH A...